Disorders Associated With Peritoneal Dialysis
11
1
1
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
27%
3 trials in Phase 3/4
14%
1 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (11)
Assessment of Bioimpedance and Vitamin D and LV Mass in PD Patients (FLUID Study)
Peritoneal Dialysis Registration System (PERSIST)
The Cardiovascular Protective Effects of Febuxostat in Peritoneal Dialysis Patients
Peritoneal Dialysis as an Option of Unplanned Initiation of Chronic Dialysis
Fosrenol and Phosphorus Balance - Lanthanum Carbonate
A Controlled and Multi-Center Study of 2500ml Huaren Peritoneal Dialysate
A Study of Domestic Automated Peritoneal Dialysis Machine
Study to Evaluate the Effects Icodextrin Versus Dianeal on Insulin Resistance in Nondiabetic Automated Peritoneal Dialysis Patients
The Association Between Arterial Stiffness and Assessment of Hydration State in Peritoneal Dialysis Patients
Effects of Aceis on Peritoneal Protein Loss and Solute Transport in pd Patients
Effect of Glucose Degradation Products (GDP) on Endothelial Dysfunction